Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Rating) announced a dividend on Friday, July 29th, investing.com reports. Shareholders of record on Monday, August 8th will be given a dividend of 0.1596 per share on Wednesday, September 21st. This represents a dividend yield of 2.45%. The ex-dividend date is Friday, August 5th.
Reckitt Benckiser Group Stock Performance
OTCMKTS:RBGLY opened at $15.93 on Friday. The stock’s fifty day moving average price is $15.42 and its two-hundred day moving average price is $15.89. Reckitt Benckiser Group has a 1 year low of $14.38 and a 1 year high of $17.90. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.44 and a current ratio of 0.62.
Analysts Set New Price Targets
Several equities research analysts have issued reports on RBGLY shares. Barclays increased their target price on Reckitt Benckiser Group from GBX 8,600 ($103.61) to GBX 9,500 ($114.46) in a research report on Thursday. UBS Group increased their price objective on Reckitt Benckiser Group from GBX 8,400 ($101.20) to GBX 8,700 ($104.82) in a research report on Thursday. Royal Bank of Canada upgraded Reckitt Benckiser Group from a “sector perform” rating to an “outperform” rating in a research report on Wednesday, May 18th. Sanford C. Bernstein upgraded Reckitt Benckiser Group from an “underperform” rating to a “market perform” rating in a research report on Thursday. Finally, Berenberg Bank lowered their price target on Reckitt Benckiser Group from GBX 7,700 ($92.77) to GBX 7,375 ($88.86 ) in a research report on Tuesday, July 19th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and five have given a buy rating to the stock. According to da ta from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $8,018.75.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to email@example.com.
Should you invest $1,000 in Reckitt Benckiser Group right now?
Before you consider Reckitt Benckiser Group, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Reckitt Benckiser Group wasn’t on the list.
While Reckitt Benckiser Group currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The 5 Stocks Here